Victory Capital Management Inc Oramed Pharmaceuticals Inc. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$3.72 - $9.0 $50,978 - $123,336	-13,704 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$8.19 - $13.89 $3,226 - $5,472	394 Added 2.96%	13,704 $70,000
Q4 2021 Feb 07, 2022	BUY	$12.98 - $29.75 $172,763 - $395,972	13,310 New	13,310 $190,000
Q2 2020 Aug 07, 2020	SELL	$2.87 - $4.12 $9,003 - $12,924	-3,137 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$2.6 - $5.5 $1,825 - $3,861	702 Added 28.83%	3,137 $10,000
Q4 2019 Feb 04, 2020	SELL	$2.43 - $5.74 $89 - $212	-37 Reduced 1.5%	2,435 $13,000
Q3 2019 Nov 12, 2019	BUY	$2.88 - $3.96 $7,119 - $9,789	2,472 New	2,472 $8,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.